Drug Type Gene therapy, Cell therapy |
Synonyms MT-102 (Myeloid Therapeutics) |
Target |
Mechanism HER2 antagonists(Receptor protein-tyrosine kinase erbB-2 antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization Myeloid Therapeutics, Inc.Startup |
Active Organization- |
Inactive Organization Myeloid Therapeutics, Inc.Startup |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Solid tumor | Preclinical | - | Myeloid Therapeutics, Inc.Startup | - |